Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate SeaStar Medical Holding Corporation before investing.

In this article, we go over a few key elements for understanding SeaStar Medical Holding Corporation’s stock price such as:

• SeaStar Medical Holding Corporation’s current stock price and volume
• Why SeaStar Medical Holding Corporation’s stock price changed recently
• Upgrades and downgrades for ICU from analysts
• ICU’s stock price momentum as measured by its relative strength

About SeaStar Medical Holding Corporation (ICU)

Before we jump into SeaStar Medical Holding Corporation’s stock price, history, target price and what caused it to recently dip, let’s take a look at some background.

SeaStar Medical Holding Corporation, a commercial-stage healthcare company, develops a proprietary platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers the selective cytopheretic device (SCD), which is a disease-modifying device that neutralizes over-active immune cells and stops the cytokine storm that yields destructive hyperinflammation; and QUELIMMUNE, an SCD therapy for pediatric patients with acute kidney injury (AKI) due to sepsis. It also develops NEUTRALIZE-AKI, an SCD therapy that is in clinical trials for adult patients with AKI; and other products in various therapeutic areas, including cardiorenal syndrome, hepatorenal syndrome, and myocardial stunning in end-stage renal disease. SeaStar Medical Holding Corporation was founded in 2007 and is headquartered in Denver, Colorado.

Want to learn more about SeaStar Medical Holding Corporation’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about SeaStar Medical Holding Corporation.

SeaStar Medical Holding Corporation’s Stock Price as of Market Close

As of July 31, 2026, 12:02 PM, CST, SeaStar Medical Holding Corporation’s stock price was $3.110.

SeaStar Medical Holding Corporation is down 2.2% from its previous closing price of $3.180.

During the last market session, SeaStar Medical Holding Corporation’s stock traded between $3.060 and $3.330. Currently, there are approximately 3.92 million shares outstanding for SeaStar Medical Holding Corporation.

SeaStar Medical Holding Corporation’s trailing earnings per share are negative, so the stock does not have a meaningful P/E ratio. We suggest investors evaluate other financial metrics to understand its overall valuation.

SeaStar Medical Holding Corporation Stock Price History

SeaStar Medical Holding Corporation’s (ICU) price is currently down 15.26% so far this month.

During the month of July, SeaStar Medical Holding Corporation’s stock price has reached a high of $5.380 and a low of $3.060.

Over the last year, SeaStar Medical Holding Corporation has hit prices as high as $12.500 and as low as $2.070. Year to date, SeaStar Medical Holding Corporation’s stock is up 29.58%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused SeaStar Medical Holding Corporation Stock’s Price to Dip?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of July 30, 2026, there were analysts who downgraded SeaStar Medical Holding Corporation’s stock and analysts who upgraded over the last month.

Additionally, you'll want to evaluate SeaStar Medical Holding Corporation’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on SeaStar Medical Holding Corporation’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

SeaStar Medical Holding Corporation’s current valuation based on AAII’s Value Grade is a F, which means it is considered to be Ultra Expensive.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about SeaStar Medical Holding Corporation (ICU) by visiting AAII Stock Evaluator.

Relative Price Strength of SeaStar Medical Holding Corporation

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of July 30, 2026, SeaStar Medical Holding Corporation has a weighted four-quarter relative price strength of -14.40%, which translates to a Momentum Score of 17 and is considered to be Very Weak.

Want to learn more about how SeaStar Medical Holding Corporation is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

SeaStar Medical Holding Corporation Stock Price: Bottom Line

As of July 31, 2026, SeaStar Medical Holding Corporation’s stock price is $3.110, which is down 2.2% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like SeaStar Medical Holding Corporation stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.